Bendamustine/Obinutuzumab Followed by Obinutuzumab Regimen

Preferred Label : Bendamustine/Obinutuzumab Followed by Obinutuzumab Regimen;

NCIt synonyms : Bendamustine/Obinutuzumab Followed by Obinutuzumab; Bendamustine/Gazyva Followed by Gazyva Regimen; Bendamustine-Obinutuzumab Followed by Obinutuzumab; Bendamustine-Obinutuzumab Followed by Obinutuzumab Regimen; Obinutuzumab/Bendamustine Followed by Obinutuzumab; Bendamustine Plus Obinutuzumab Followed by Obinutuzumab Regimen;

NCIt definition : A regimen consisting of bendamustine and obinutuzumab followed by obinutuzumab that may be used in the treatment of some forms of non-Hodgkin's lymphoma (NHL), including follicular lymphoma, gastric and nongastric, noncutaneous mucosa-associated lymphoid tissue (MALT) lymphoma, and nodal and splenic marginal zone lymphoma.;

NCI Metathesaurus CUI : CL1798458;

Details

Origin ID

C189669;

UMLS CUI

C5708677;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bendamustine Hydrochloride [NCIt concept]
- Obinutuzumab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients